Modified-Release Dosage Forms of 5-Ht2c Agonists Useful for Weight Management
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Sep 12, 2019
app pub date -
Jan 7, 2019
filing date -
Jan 7, 2019
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention relates to methods for weight management that utilize modified-release dosage forms comprising (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts and crystalline forms thereof. The present invention further relates to (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts, crystalline forms thereof and modified-release dosage forms comprising them.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully